Literature DB >> 7068212

Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.

J C Williams, J L Cantrell.   

Abstract

Vaccines prepared from Formalin-killed whole cells of Coxiella burnetii (Ohio strain) or from chloroform-methanol residue (CMR) and extract (CME) of such cells were examined for biological and immunological properties in male C57BL/10ScN endotoxin nonresponder mice. Vaccines containing killed whole cells induced a high incidence of gross pathology, as evidenced by liver necrosis, significant splenomegaly, and significant hepatomegaly in mice. The degree and onset of these pathological changes were directly and inversely proportional, respectively, to the dosage of killed organisms administered. Conversely, no splenomegaly, hepatomegaly, or liver necrosis were observed in mice inoculated with CMR or CME. Moreover, killed whole cells were lethal for mice at dosages of 150 to 1,200 micrograms, whereas no deaths were seen in animals given 1,200 micrograms of CMR. In addition, antibodies against phase I and phase II antigens of C. burnetii were detected in the sera of mice inoculated with either whole cells or CMR. Enhanced blastogenic response of splenic lymphocytes was observed when animals were vaccinated with killed whole cells and CMR but not with CME. Moreover, 80 to 90% of mice inoculated with 300 micrograms of the CMR were protected against a lethal challenge of viable rickettsiae, whereas only 50% of the animals given 300 micrograms of killed whole cells were protected. Treatments with CME were essentially without value, since no antibodies were detectable and no significant protection was elicited. Collectively, these results show that, although killed whole cells induced immunity in C57BL/10ScN mice, they induced deleterious tissue reactions, whereas CMR, which also induced immunity, was essentially nondeleterious, based on the parameters employed. These observations suggest that the chloroform-methanol-extractable component(s) is implicated in the deleterious tissue reactions and that the phase I and II antigens may not be involved in the induction of the pathology observed in C57BL/10ScN mice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068212      PMCID: PMC351159          DOI: 10.1128/iai.35.3.1091-1102.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  STUDY OF THE ANTIGENIC STRUCTURE OF COXIELLA BURNETI. 3. PYROGENIC EFFECT OF PHASE I ANTIGEN IN EXPERIMENTAL GUINEA PIGS.

Authors:  R BREZINA; S SCHRAMEK; J URVOELGYI
Journal:  Acta Virol       Date:  1965-03       Impact factor: 1.162

2.  [Solution of active specific prevention of Q fever. I. Experiments on guinea pigs].

Authors:  L V VASIL'EVA; V A IABLONSKAIA
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1955-06

3.  Chronic Q fever.

Authors:  W P Turck; G Howitt; L A Turnberg; H Fox; M Longson; M B Matthews; R Das Gupta
Journal:  Q J Med       Date:  1976-04

4.  Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols.

Authors:  R A Kishimoto; G T Burger
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

6.  Limits of rickettsial infectivity.

Authors:  R Ormsbee; M Peacock; R Gerloff; G Tallent; D Wike
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine.

Authors:  R A Kishimoto; J W Johnson; R H Kenyon; M S Ascher; E W Larson; C E Pedersen
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

8.  Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components.

Authors:  J C Williams; M G Peacock; T F McCaul
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  Analysis of antibody response and immunoglobulins in sera of rabbits and guinea pigs immunized with Coxiella burnetii.

Authors:  J Kazár; S Schramek; R Brezina
Journal:  Acta Virol       Date:  1977-05       Impact factor: 1.162

10.  Some physiological and biochemical effects of a Coxiella burneti lipopolysaccharide preparation on guinea pigs.

Authors:  O G Baca; D Paretsky
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more
  28 in total

Review 1.  Animal models of Q fever (Coxiella burnetii).

Authors:  Kevin R Bewley
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

2.  Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; K T McKee; G Sandstrom; L L Pratt; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

3.  Long-Term immune responses to Coxiella burnetii after vaccination.

Authors:  Gilbert J Kersh; Kelly A Fitzpatrick; Joshua S Self; Brad J Biggerstaff; Robert F Massung
Journal:  Clin Vaccine Immunol       Date:  2012-11-28

4.  Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.

Authors:  Ying Peng; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

5.  A heat shock operon in Coxiella burnetti produces a major antigen homologous to a protein in both mycobacteria and Escherichia coli.

Authors:  M H Vodkin; J C Williams
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

6.  Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.

Authors:  L F Fries; D M Waag; J C Williams
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

Review 7.  Q fever and Coxiella burnetii: a model for host-parasite interactions.

Authors:  O G Baca; D Paretsky
Journal:  Microbiol Rev       Date:  1983-06

8.  Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii.

Authors:  K Amano; J C Williams
Journal:  J Bacteriol       Date:  1984-12       Impact factor: 3.490

9.  Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions.

Authors:  M S Ascher; J C Williams; M A Berman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.

Authors:  David M Waag; Marilyn J England; Christopher R Bolt; Jim C Williams
Journal:  Clin Vaccine Immunol       Date:  2008-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.